Rhumbline Advisers View Ray, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$0.35 - $3.28 $1,796 - $16,836	-5,133 Reduced 2.6%	192,479 $67,000
Q1 2023 May 11, 2023	BUY	$3.28 - $4.81 $28,391 - $41,635	8,656 Added 4.58%	197,612 $684,000
Q4 2022 Feb 14, 2023	BUY	$3.65 - $4.82 $17,520 - $23,136	4,800 Added 2.61%	188,956 $847,000
Q3 2022 Nov 10, 2022	BUY	$2.66 - $3.97 $42,804 - $63,885	16,092 Added 9.57%	184,156 $670,000
Q2 2022 Aug 11, 2022	BUY	$2.42 - $4.05 $60,971 - $102,039	25,195 Added 17.64%	168,064 $445,000
Q1 2022 May 12, 2022	BUY	$3.45 - $5.83 $38,650 - $65,313	11,203 Added 8.51%	142,869 $560,000
Q4 2021 Feb 10, 2022	SELL	$4.89 - $7.59 $4,141 - $6,428	-847 Reduced 0.64%	131,666 $725,000
Q3 2021 Nov 12, 2021	BUY	$5.18 - $7.41 $32,898 - $47,060	6,351 Added 5.03%	132,513 $955,000
Q2 2021 Aug 05, 2021	SELL	$3.94 - $6.75 $83,090 - $142,350	-21,089 Reduced 14.32%	126,162 $833,000
Q1 2021 May 06, 2021	SELL	$4.03 - $7.25 $22,910 - $41,216	-5,685 Reduced 3.72%	147,251 $641,000
Q4 2020 Feb 10, 2021	BUY	$2.78 - $4.5 $48,016 - $77,724	17,272 Added 12.73%	152,936 $584,000
Q3 2020 Nov 12, 2020	SELL	$2.12 - $3.53 $43,746 - $72,841	-20,635 Reduced 13.2%	135,664 $475,000
Q2 2020 Aug 13, 2020	BUY	$1.66 - $2.73 $109,561 - $180,182	66,001 Added 73.09%	156,299 $350,000
Q1 2020 May 06, 2020	BUY	$1.35 - $4.05 $5,805 - $17,415	4,300 Added 5.0%	90,298 $226,000
Q4 2019 Feb 05, 2020	BUY	$2.3 - $4.6 $1,741 - $3,482	757 Added 0.89%	85,998 $363,000
Q3 2019 Oct 23, 2019	SELL	$2.9 - $9.56 $6,336 - $20,888	-2,185 Reduced 2.5%	85,241 $247,000
Q2 2019 Aug 14, 2019	BUY	$6.7 - $9.13 $57,063 - $77,760	8,517 Added 10.79%	87,426 $770,000
Q1 2019 May 01, 2019	BUY	$5.7 - $8.73 $7,193 - $11,017	1,262 Added 1.63%	78,909 $583,000
Q4 2018 Jan 31, 2019	BUY	$5.04 - $10.28 $153,034 - $312,141	30,364 Added 64.22%	77,647 $471,000
Q3 2018 Nov 07, 2018	BUY	$7.12 - $12.44 $17,009 - $29,719	2,389 Added 5.32%	47,283 $443,000
Q2 2018 Aug 06, 2018	BUY	$6.21 - $8.21 $112,866 - $149,216	18,175 Added 68.02%	44,894 $311,000
Q1 2018 May 02, 2018	BUY	$6.26 - $10.12 $8,138 - $13,155	1,300 Added 5.11%	26,719 $172,000
Q4 2017 Feb 09, 2018	SELL	$5.6 - $9.9 $29,276 - $51,757	-5,228 Reduced 17.06%	25,419 $235,000
Q3 2017 Nov 06, 2017	BUY	$4.73 - $6.16 $144,960 - $188,785	30,647	30,647 $177,000

Others Institutions Holding VRAY

# of Institutions

Shares Held

645K

Call Options Held

50K

Put Options Held

30K

View Full List

About ViewRay, Inc.

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

More about VRAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account